Name: Epiminder (EPI) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

EPI

Health Care Equipment & Services

Epiminder

Short interest: <0.01%; −0.01 pp 30d; as of 2 Nov 2026
Reported shorts: 2.5K
Shares on issue: 175.186M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Epiminder

Epiminder is focused on transforming epilepsy management through its innovative Minder system, the first FDA-authorised implantable continuous EEG monitoring (iCEM) system. This technology provides continuous, long-term EEG monitoring, offering enhanced treatment planning and remote care capabilities for patients with drug-resistant epilepsy. Epiminder aims to improve the quality of life for epilepsy patients by providing actionable information regarding seizures and other EEG events.

Company profile →

Epiminder (ASX:EPI) has <0.01% of its shares on issue reported as short positions as of 2 Nov 2026, or about 2,547 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. EPI is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 45, 2026.

Strategy fit

How each stock picker strategy reads EPI today

Zanger BreakoutWatchScore 33rank 487 of 1022
CAN SLIMWatchScore 18rank 672 of 883
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutNot a candidate
Quality compoundersWatchScore 10rank 939 of 1079

Prices to 6 Nov 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

EPI fundamentals

In the year to 30 Jun 2026, Epiminder (ASX:EPI) recorded revenue of A$2.1M and a net loss after tax of A$42.7M. A year earlier it recorded revenue of A$445.2K and a net loss after tax of A$34.5M. Year-on-year growth: revenue +378.9% (FY). Net margin −2,004.4%, return on equity −45.2% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 29 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →